• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Can Computerized Interventions Reduce Cannabis Use?

Can Computerized Interventions Reduce Cannabis Use?

July 1, 2018
Thomas Jordan, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Thomas Jordan, MD Dr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

REVIEW OF: Olmos A et al, Addict Behav 2018;79:52–60

As medical and recreational marijuana become legalized in more states, more emphasis is being placed on treatment of those with cannabis use disorders. But with our clinics already at capacity, how can we find the most efficient way of providing therapy? Computerized interventions are already available for nicotine and alcohol use, but what about for cannabis?

This meta-analysis included 9 randomized control trials evaluating the efficacy of web-based treatments designed to reduce the frequency of cannabis use. The primary outcome was reduction in cannabis use, and the secondary outcome was reduction in other substance use. A total of 2,963 participants were included in the studies—1,724 in the intervention groups and 1,239 in the control groups. All the interventions were computer-based, and the control conditions varied from study to study—from no intervention to psychoeducation.

So, how did the computer-based interventions fare? Those who participated in the computerized interventions had a significant reduction in cannabis use when compared to the control groups (SMD: -0.19; 95% CI: -0.26 to -0.11), with no significant heterogeneity among the studies (I2 = 0%). Only 3 of the 9 trials collected data on the secondary outcome of reduction in other substance use, but there was again a significant reduction in those studies compared to the control condition (SMD: -0.27; 95% CI: -0.46 to -0.08), with low heterogeneity (I2 = 26%). Several sub-group analyses were performed, but the only significant result was in the number of sessions—interventions with ≥ 5 sessions performed better than those with < 5 sessions (SMD: -0.21; 95% CI -0.29 to -0.12).

CATR’s Take
With more people seeking treatment for substance use disorders, we need more options to give them effective care. This analysis shows that computerized interventions can work to help patients reduce cannabis use, along with other substance use. But it’s also important to note what the study doesn’t show: There was no comparison to a live therapist intervention. Sessions with an in-person therapist are still recommended, but when that’s not available, offering a computer-based intervention may be a good option.
Addiction Treatment
KEYWORDS research-update substance_abuse
    Thomas Jordan, MD

    Do Psychosocial Interventions Improve Quality of Life in Advanced Dementia?

    More from this author
    www.thecarlatreport.com
    Issue Date: July 1, 2018
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - Adolescent Addiction, CATR July/August 2018
    Adolescents With ADHD and Substance Use Disorders: A Primer
    Talking to Parents and Adolescent Patients About Substance Use
    Can Computerized Interventions Reduce Cannabis Use?
    Substance Use Disorders Are Under-Recognized in Patients With Diabetes
    Featured Book
    • OUDFB1e_Cover_Binding.png

      Treating Opioid Use Disorder—A Fact Book (2024)

      All the tools you need to assess and treat patients struggling with opioid use disorder. 
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.